We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

128 hedge funds and large institutions have $520M invested in Intersect ENT, Inc in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 58 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

310% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 10

222% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 18

88% more capital invested

Capital invested by funds: $277M → $520M (+$244M)

32% more funds holding

Funds holding: 97128 (+31)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
128
Holders Change
+31
Holders Change %
+31.96%
% of All Funds
3.45%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
41
Increased
58
Reduced
18
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
126
Invesco
Georgia
$5K +$5.01K +191 New
AH
127
Achievement Holdings
Illinois
$859 +$786K +30,000 New
Manulife (Manufacturers Life Insurance)
128
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$277 +$169K +6,457 +201%
T. Rowe Price Associates
129
T. Rowe Price Associates
Maryland
-$5.85M -226,416 Closed
CCI
130
Columbus Circle Investors
-$2.37M -91,898 Closed
ASP
131
Adams Street Partners
Illinois
-$2.13M -82,500 Closed
TI
132
Turner Investments
Pennsylvania
-$1.85M -71,510 Closed
YU
133
Yale University
Connecticut
-$1.09M -42,334 Closed
CAD
134
Craig A. Drill
-$590K -22,847 Closed
Zurich Cantonal Bank
135
Zurich Cantonal Bank
Switzerland
-$506K -19,575 Closed
Goldman Sachs
136
Goldman Sachs
New York
-$442K -17,123 Closed
AAP
137
Ardsley Advisory Partners
Connecticut
-$387K -15,000 Closed
AP
138
AlpInvest Partners
Netherlands
-$213K -8,250 Closed

XENT Hedge Fund Activity: Q2 2015 in Review

128 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2015, worth a combined $520M — up 88% from $277M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new XENT positions and 10 closed out — a net gain of 31 holders — while 58 added to existing stakes and 18 trimmed.

The largest buyer was Jennison Associates, adding an estimated $25.1M. The largest seller was Norwest Venture Partners XI, cutting an estimated $5.88M.

  • 128 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2015, up from 97 in Q1 2015.
  • Funds reported $520M of Intersect ENT, Inc stock for Q2 2015, up 88% quarter-over-quarter.
  • 41 funds opened new Intersect ENT, Inc positions in Q2 2015 and 10 closed out, a net change of +31 holders.
  • The largest Intersect ENT, Inc buyer in Q2 2015 was Jennison Associates, an estimated $25.1M added.
  • The largest Intersect ENT, Inc seller in Q2 2015 was Norwest Venture Partners XI, an estimated $5.88M sold.

Based on aggregated 13F filings for Q2 2015.